Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting is a recognised side effect of Mounjaro (tirzepatide). It affects a minority of people, most often in the first few weeks of treatment or after a dose increase, and it typically settles as the body adjusts. Knowing what to expect, and when vomiting with Mounjaro crosses a line that needs medical attention, makes a real difference to how you manage it. This page covers both — clearly, without alarm, and without brushing over the parts that genuinely matter. Mounjaro is a prescription-only medicine; a prescriber assesses your full health picture before recommending it, and that conversation includes side effects like this one.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro slows the rate at which the stomach empties. That is part of how it reduces appetite, but it can also leave food and acid sitting in the stomach for longer than usual, which some people experience as nausea that tips into vomiting. The NHS tirzepatide medicines page lists nausea, vomiting and diarrhoea as the most frequently reported side effects, and the pattern is consistent: symptoms tend to peak in the first week or two after each dose change, then ease.
The 2.5mg starting dose exists specifically to let your body acclimatise before the dose is increased. Some people sail through it; others find the first few weeks genuinely uncomfortable. Neither experience says anything certain about how you will get on at a higher dose. The gut adapts. Most people who vomit in week two of their first pen are not vomiting in week six.
Eating habits matter here too. Large meals, fatty or very rich food, and eating too quickly can all amplify the effect. Smaller portions, eaten slowly, tend to reduce it. Our page on side effects after eating on Mounjaro covers the practical adjustments in more detail.
Most vomiting on Mounjaro is self-limiting and manageable. But there are situations where you should not wait it out. The decision point is straightforward: if vomiting is stopping you keeping fluids down for several hours, you are at real risk of dehydration, which can affect the kidneys. Contact your prescriber, your GP, or NHS 111.
The more urgent situation is severe, persistent stomach pain that reaches the back, particularly if vomiting accompanies it. In January 2026, the MHRA issued a Drug Safety Update specifically about GLP-1 medicines and acute pancreatitis, an infrequent but serious condition that GLP-1 receptor agonists can trigger in some people. If that pattern of pain appears, stop the injection and get urgent medical help. Do not wait to see if it settles.
Other signs to act on: signs of an allergic reaction (swelling around the face or throat, difficulty breathing), blood in vomit, or vomiting so severe that you cannot take other medicines you rely on. These situations go beyond a phone call to your prescriber; call 999 or go to A&E.
If you are uncertain about a symptom, our overview of Mounjaro safety sets out the full picture of what to watch for.
A question our prescribers hear regularly is whether vomiting means stopping the medicine altogether. Not always. There are several things worth trying first, and the right answer depends on how severe your symptoms are and how long they have lasted, which is a conversation for your prescriber, not a decision to make alone at 7am.
That said, the adjustments that commonly help are well-established. Eat smaller amounts, more often, rather than two or three large meals. Avoid eating right up until bedtime. Give rich, fatty or heavily spiced food a wide berth, at least while your dose is new. Staying upright for a while after eating helps gastric emptying. Hydration between meals, rather than with them, can reduce the feeling of a full stomach tipping over.
If you moved up to a new dose and vomiting became much worse, talk to your prescriber about whether the timing of that step was right. A slower titration is an option for some people. You can read more about the broader side effect picture on our Mounjaro side effects page, and about how vomiting and diarrhoea can occur together on our page covering vomiting and diarrhoea on Mounjaro.
This is one of the most common practical worries, and it is worth addressing clearly. Mounjaro is a subcutaneous injection, meaning it goes under the skin, not into the stomach. Vomiting after mounjaro has been injected does not remove the dose from your body. The medicine is already in your subcutaneous tissue and will absorb regardless of what your stomach is doing.
Where this gets more complicated is if you vomit and also take oral contraceptives. Tirzepatide slows gastric emptying in a way that may reduce how well the pill is absorbed, particularly in the early weeks of treatment. The NHS advises adding a non-oral method of contraception for the first four weeks of Mounjaro and for four weeks after each dose increase, as a precaution. If vomiting is also affecting your pill-taking routine, discuss that specifically with your prescriber.
Questions about whether what you are experiencing is typical are common, and our pages on whether it is normal to vomit on Mounjaro and whether Mounjaro can cause vomiting address the frequency question in depth. For anyone considering treatment and weighing this up, our prescribers discuss side effects as part of every consultation, you can check your eligibility and start a free consultation to have that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.